Search the Newsreel

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that EquipmentShare.com, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - EQPT

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of EquipmentShare.com, Inc. (NASDAQ: EQPT): (i) Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in …

Kaplan Fox Encourages EquipmentShare.Com Inc (NASDAQ: EQPT) Inves

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against EquipmentShare.Com Inc (NASDAQ: EQPT) on behalf of investors who purchased shares during the IPO or between January 23, 2026, and June 23, 2026. The lawsuit alleges that the company failed to disclose …

The Gross Law Firm Reminds Equipmentshare.com Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 21, 2026 - EQPT

The Gross Law Firm is reminding investors of Equipmentshare.com Inc. (NASDAQ: EQPT) about a pending class action lawsuit with a lead plaintiff deadline of September 21, 2026. The lawsuit alleges that the company made materially false and/or misleading statements regarding undisclosed related party transactions …

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages EquipmentShare.com Inc Investors to Secure Counsel Before Important Deadline in Securities Class Action - EQPT

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of EquipmentShare.com Inc (NASDAQ: EQPT): (i) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued …

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on August …

Taysha Gene Therapies, Inc. (TSHA): Investor Outlook Reveals A Potential 108.99% Upside

Taysha Gene Therapies, Inc. (TSHA), a clinical-stage biotechnology firm, is attracting investor attention due to its promising pipeline in adeno-associated virus-based gene therapies for severe monogenic central nervous system diseases. Despite current negative financial metrics typical of developmental biotech firms, analysts project a potential …

EQPT Deadline Alert: SueWallSt Reminds EquipmentShare.com Inc. (EQPT) Investors of Securities Class Action Deadline on September 21, 2026

SueWallSt has filed a securities class action lawsuit against EquipmentShare.com Inc. (EQPT) on behalf of investors who purchased shares between January 23, 2026, and June 23, 2026. The lawsuit alleges that EquipmentShare made materially false and misleading statements regarding undisclosed related-party transactions, leading to …

Lowey Dannenberg, P.C. is Investigating EquipmentShare.com Inc. (NASDAQ: EQPT) for Potential Violations of the Federal Securities Laws

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating EquipmentShare.com Inc. (NASDAQ: EQPT) (“EquipmentShare” or the “Company”) for potential violations of the federal securities laws. On or around January …

Manufacturing deal prepares Rett gene therapy for potential U.S. launch

Taysha Gene Therapies has announced a commercial supply agreement with Catalent to prepare for the potential U.S. launch of TSHA-102, an experimental gene therapy for Rett syndrome. Catalent will serve as the primary commercial manufacturer if TSHA-102 receives FDA approval, building on their existing …

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A

Bernstein Liebhard LLP has filed a securities class action lawsuit against EquipmentShare.com, Inc. (EQPT) on behalf of investors who purchased shares during or after its January 2026 IPO or between January 23, 2026, and June 23, 2026. The lawsuit alleges that EquipmentShare made false …

EQPT UPCOMING DEADLINE : The Gross Law Firm Alerts Equipmentshare.com Inc. Stockholders of Securities Class Action - Contact the Firm

The Gross Law Firm has issued an alert to stockholders of Equipmentshare.com Inc. (NASDAQ: EQPT) regarding a securities class action lawsuit. Shareholders who purchased EQPT shares during the class period of January 23, 2026, to June 23, 2026, are encouraged to contact the firm, …

EQPT Investors Have Opportunity to Lead EquipmentShare.com Inc Securities Lawsuit

The Rosen Law Firm is reminding investors who purchased EquipmentShare.com Inc (NASDAQ: EQPT) securities during the Class Period (January 23, 2026, to June 23, 2026) of the upcoming September 21, 2026, lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that …

Taysha Sets Aug. 11 Webcast on Rare-Disease Gene Therapies

Taysha Gene Therapies (Nasdaq: TSHA) will report its second-quarter 2026 financial results and host a corporate update conference call and webcast on Tuesday, August 11, 2026, at 4:30 PM Eastern Time. The company, focused on AAV-based gene therapies for severe monogenic CNS diseases, will …

ROSEN, LEADING INVESTOR COUNSEL, Encourages EquipmentShare.com Inc Investors to Secure Counsel Before Important Deadline in Securities Class Action - EQPT

The Rosen Law Firm is reminding investors of EquipmentShare.com Inc (NASDAQ: EQPT) about the September 21, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that EquipmentShare made materially false and/or misleading statements regarding undisclosed related-party transactions and financial statements. …

Kaplan Fox & Kilsheimer LLP Alerts EquipmentShare.Com Inc. (NASDAQ: EQPT) Investors to the Lead Plaintiff Deadline on September 21, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against EquipmentShare.Com Inc. (NASDAQ: EQPT) following a significant stock price drop after a report alleged undisclosed related-party transactions. Investors who purchased shares during the IPO or between January 23, 2026, and June 23, …

Taysha Gene Therapies (TSHA) to Announce Quarterly Earnings on Tuesday

Taysha Gene Therapies to Release Second Quarter 2026

Taysha Gene Therapies announced it will report its second-quarter 2026 financial results and host a conference call and webcast on Tuesday, August 11, 2026, at 4:30 PM Eastern Time. The clinical-stage biotechnology company focuses on developing AAV-based gene therapies for severe monogenic diseases of …

Kaplan Fox Urges Investors of EquipmentShare.Com Inc (EQPT) with Significant Losses to Seek a Leadership Role Before September 21, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against EquipmentShare.Com Inc (EQPT) on behalf of investors who purchased shares during or traceable to the IPO on or around January 23, 2026, or between January 23, 2026, and June 23, 2026. The …

Kaplan Fox Encourages EquipmentShare.Com Inc (NASDAQ: EQPT) Investors to Contact the Firm Before the Deadline on September 21, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against EquipmentShare.Com Inc (NASDAQ: EQPT) for investors who purchased stock during or after its IPO on January 23, 2026. The lawsuit follows a report by Umibozu Research alleging undisclosed related-party transactions that caused …

Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome

Taysha Gene Therapies and Catalent have expanded their strategic partnership to include commercial manufacturing support for TSHA-102, Taysha’s gene therapy for Rett syndrome. Catalent will serve as the primary commercial manufacturer following potential FDA approval, ensuring long-term capacity and a scalable supply. This agreement …

EquipmentShare Investors With Significant Losses Should Contact Robbins LLP for Information About Leading the EQPT Class Action Lawsuit

SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a securities class action has been filed on behalf of shareholders who purchased or otherwise acquired EquipmentShare.com, Inc. (NASDAQ: EQPT) securities: (1) Class A common stock issued in connection with the …

Taysha secures commercial manufacturing deal with Catalent

Taysha Gene Therapies announced a commercial supply agreement with Catalent, Inc. for TSHA-102, an investigational gene therapy for Rett syndrome. Catalent will serve as Taysha’s primary commercial manufacturer after potential U.S. FDA approval, providing GMP manufacturing and commercial supply from its facility in Harmans, …

Taysha’s Rett Gene Therapy Gets a Future Commercial Manufacturer

Taysha Gene Therapies and Catalent have expanded their partnership with a commercial supply agreement for TSHA-102, an investigational gene therapy for Rett syndrome. Under the agreement, Catalent will serve as the primary commercial manufacturer for TSHA-102 following potential U.S. FDA approval, leveraging its FDA-licensed …

EQPT Class Action Notice: EquipmentShare Hit with Securities Fraud Lawsuit over Related Party Transactions – Investors Urged to Contact BFA Law by September 21 Deadline

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against EquipmentShare.com, Inc. (NASDAQ:EQPT) and certain of the company’s senior executives for securities law violations after significant stock …

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Planet Fitness, Inc. (PLNT), Microvast Holdings, Inc. (MVST), and EquipmentShare.com, Inc. (EQPT) Announced by Holzer & Holzer, LLC

ATLANTA, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Planet Fitness, Inc. (PLNT) The shareholder class action lawsuit filed against Planet Fitness, Inc. (“Planet …

Catalent, Taysha extend AAV-based gene therapy partnership

Taysha Gene Therapies and Catalent have announced a commercial supply agreement for TSHA-102, Taysha’s investigational gene therapy for Rett syndrome. This agreement extends their partnership, securing long-term manufacturing capacity and a scalable supply framework for TSHA-102 after potential FDA approval. Catalent will provide GMP …

EquipmentShare.com, Inc. Class A Revenue Breakdown – MUN:4ZV

EquipmentShare.com, Inc. Class A (MUN:4ZV) generated €3.73 billion in revenue last year, primarily from its Equipment Rental and Services segment, which contributed €2.32 billion. The United States was the company's largest market, accounting for the entire €3.73 billion in revenue. This information details the …

EquipmentShare.com (Nasdaq:EQPT) - Stock Analysis

This article provides a stock analysis of EquipmentShare.com (EQPT), highlighting its strong future growth prospects with earnings forecast to grow by 49.51% annually and a profitable year. Despite trading at a good value, the company faces risks such as volatile share price and interest …

Taysha Gene Therapies Inc (TSHA) Institutional Confidence

Taysha Gene Therapies Inc (TSHA) has an institutional shareholding score of 10.00, ranking 1st in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 100.06%, showing a 1.93% increase quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 358.26K shares.

DEADLINE ALERT for MVST, PRIM, and EQPY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, July 31, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead …

INVESTOR NOTICE: EquipmentShare.com, Inc. (EQPT) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO, July 31, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of EquipmentShare.com, Inc. (NASDAQ: EQPT): (i) Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with EquipmentShare.com’s January …

EquipmentShare.com Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against EquipmentShare.com Inc.

ClaimsFiler is reminding investors with losses exceeding $100,000 in EquipmentShare.com Inc. (NasdaqGS: EQPT) of the September 21, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that EquipmentShare and its executives failed to disclose material information regarding undisclosed related party …

Taysha Gene Therapies Inc (TSHA) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Taysha Gene Therapies Inc (TSHA), detailing its current valuation score of 8.53, ranking 113 out of 384 in the Biotechnology & Medical Research industry. It highlights the company's current P/E ratio of -15.60, noting its position relative …

EquipmentShare Announces Second Quarter 2026 Financial Results Conference Call

EquipmentShare.com Inc. (Nasdaq: EQPT) announced it will report its fiscal second quarter 2026 financial results after the market closes on Wednesday, August 12, 2026. A conference call will be held on Thursday, August 13, 2026, at 7:30 a.m. Central Time to discuss the results, …

Kaplan Fox Urges EquipmentShare.Com Inc (NASDAQ: EQPT) Investors to Contact the Firm Before the Deadline on September 21, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against EquipmentShare.Com Inc (NASDAQ: EQPT) on behalf of investors who purchased shares related to its IPO between January 23, 2026, and June 23, 2026. The lawsuit stems from allegations of undisclosed related-party transactions …

Time To Take A Look At Taysha: Rett Syndrome Gene Therapy Trial On Track For Key Interim Analysis

Taysha Gene Therapies is advancing its gene therapy trial for Rett syndrome, a rare neurodevelopmental disorder caused by MECP2 gene mutations, towards a key interim analysis. The article highlights that Rett syndrome primarily affects females, with 6,000-9,000 patients in the US, and notes that …